New Paul Hopper Interview, page-17

Agree or not big movements happen when big players start buying or in some cases ramp these up , some of the big players hit buy button only when stock has concretely derisked , I believe this will happen when we have good phase 2 trials or interest from some big pharma while we are at it ( buyout or partnership) either one of which will happen sooner than later , some of these big names in medical world who will join IMU are in fact assessors of some big pharmas imo ,will see the claimed drug performance first hand and will refer to pharmas who are interested , so pay keen attention to boards , medical consultants , new additions , addition to top 20 holders , phase 2 is critical if we get similar results as  phase 1 and can be used in conjunction with other cancer treatments this will be a blockbuster